HEPATITIS C TREATMENT IN PHARMACOTHERAPY SERVICES: INCRASING TREATMENT UPTAKE NEEDS A CRITICAL VIEW
Saved in:
TRELOAR, C.J., ET AL., HEPATITIS C TREATMENT IN PHARMACOTHERAPY SERVICES: INCRASING TREATMENT UPTAKE NEEDS A CRITICAL VIEW. DRUG AND ALCOHOL REVIEW, Vol. 28, no. 4 (2009), p. 436-440.
Ref.
160921
Location:
SIIS R.1025 Archivo
Palabras clave:
Drogas ilegales, Drogodependencias, Enfermos, Hepatitis, Opiáceos, Programas de desintoxicación, Tratamiento médico
Drogas ilegales, Drogodependencias, Enfermos, Hepatitis, Opiáceos, Programas de desintoxicación, Tratamiento médico
Similar Items: HEPATITIS C TREATMENT IN PHARMACOTHERAPY SERVICES: INCRASING TREATMENT UPTAKE NEEDS A CRITICAL VIEW
- CRITICAL ISSUES IN THE TREATMENT OF HEPATITIS C VIRUS INFECTION IN METHADONE MAINTENACE PATIENTS
- Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services
- Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy
- Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs
- TARGETS FOR HEPATITIS C VIRUS TEST UPTAKE AND CASE FINDING AMONG INJECTING DRUG USERS: IN PRISONS AND GENERAL PRACTICE
- Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs